Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clémence Romeo

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in Oncology|July 24, 2019
Current role of poly(ADP-ribose) polymerase inhibitors: which poly(ADP-ribose) polymerase inhibitor and when?Hélène Vanacker, Clémence Romeo, Isabelle Ray-Coquard
Current Opinion in Oncology|April 29, 2026
Desmoplastic small round cell tumorMehdi Brahmi, Clémence Romeo, Alexandra Meurgey, et al.
Expert Review of Anticancer Therapy|December 31, 2025
An evaluation of afamitresgene autoleucel for the treatment of advanced synovial sarcoma and myxoid round cell liposarcomaMargaux Dupont, Armelle Dufresne, Mehdi Brahmi, et al.
JCO Precision Oncology|August 10, 2023
<i>ESR1</i> Rearrangement as a Diagnostic and Predictive Biomarker in Uterine Tumor Resembling Ovarian Sex Cord Tumor: A Report of Four CasesMarta Bini, Justine Gantzer, Armelle Dufresne, et al.
Bulletin Du Cancer|September 7, 2023
Gynecological carcinosarcomas: Overview and future perspectivesLaetitia Collet, Andrea María González López, Clémence Romeo, et al.
Gynecologic Oncology|November 18, 2018
Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trialClémence Romeo, Florence Joly, Isabelle Ray-Coquard, et al.
Cancers|January 21, 2022
Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG NetworkClémence Romeo, Olivia Le Saux, Margaux Jacobs, et al.
Cancers|August 26, 2022
Real-World Data on Newly Diagnosed <i>BRCA</i>-Mutated High-Grade Epithelial Ovarian Cancers: The French National Multicenter ESME DatabaseMarta Bini, Stanislas Quesada, Pierre Meeus, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Oncology|July 24, 2019
Current role of poly(ADP-ribose) polymerase inhibitors: which poly(ADP-ribose) polymerase inhibitor and when?Hélène Vanacker, Clémence Romeo, Isabelle Ray-Coquard
Current Opinion in Oncology|April 29, 2026
Desmoplastic small round cell tumorMehdi Brahmi, Clémence Romeo, Alexandra Meurgey, et al.
Expert Review of Anticancer Therapy|December 31, 2025
An evaluation of afamitresgene autoleucel for the treatment of advanced synovial sarcoma and myxoid round cell liposarcomaMargaux Dupont, Armelle Dufresne, Mehdi Brahmi, et al.
JCO Precision Oncology|August 10, 2023
<i>ESR1</i> Rearrangement as a Diagnostic and Predictive Biomarker in Uterine Tumor Resembling Ovarian Sex Cord Tumor: A Report of Four CasesMarta Bini, Justine Gantzer, Armelle Dufresne, et al.
Bulletin Du Cancer|September 7, 2023
Gynecological carcinosarcomas: Overview and future perspectivesLaetitia Collet, Andrea María González López, Clémence Romeo, et al.
Gynecologic Oncology|November 18, 2018
Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trialClémence Romeo, Florence Joly, Isabelle Ray-Coquard, et al.
Cancers|January 21, 2022
Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG NetworkClémence Romeo, Olivia Le Saux, Margaux Jacobs, et al.
Cancers|August 26, 2022
Real-World Data on Newly Diagnosed <i>BRCA</i>-Mutated High-Grade Epithelial Ovarian Cancers: The French National Multicenter ESME DatabaseMarta Bini, Stanislas Quesada, Pierre Meeus, et al.
Pageof 1